In the last decade, the development of new radiopharmaceuticals for the imaging and therapy of prostate cancer has been a highly active and important area of research, especially focusing on the prostate-specific membrane antigen (PSMA), an antigen which is upregulated in prostate, as well as in other tumor cells. A large variety of PSMA ligands have been radiolabeled, to date. Among the various derivatives, PSMA-617 resulted to be one of the most interesting in terms of interaction with the antigen and clinical properties, and its lutetium-177 labeled version has recently been approved by regulatory agencies for therapeutic purposes. For this reasons, the radiolabeling with fluorine-18 of a PSMA-617 derivative might be of interest. Beside other methodologies to radiolabel macromolecules with fluorine-18, the “click-chemistry” approach resulted to be very useful, and the copper-catalyzed azide-alkyne cycloaddition (CuAAC) is considered one of most efficient and reliable. This paper proposes the synthesis of a suitable precursor for the radiolabeling with fluorine-18 of a new PSMA-617 derivative. The whole radiosynthetic procedure has been fully automated, and the final product, which proved to be stable in plasma, has been obtained with radiochemical yield and purity suitable for subsequent preclinical studies.

Iannone, M., Stucchi, S., Turolla, E., Beretta, C., Ciceri, S., Chinello, C., et al. (2022). Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 65(3), 48-62 [10.1002/jlcr.3959].

Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach

Iannone M. N.
;
Stucchi S.;Turolla E. A.;Beretta C.;Chinello C.;Pagani L.;Todde S.;
2022

Abstract

In the last decade, the development of new radiopharmaceuticals for the imaging and therapy of prostate cancer has been a highly active and important area of research, especially focusing on the prostate-specific membrane antigen (PSMA), an antigen which is upregulated in prostate, as well as in other tumor cells. A large variety of PSMA ligands have been radiolabeled, to date. Among the various derivatives, PSMA-617 resulted to be one of the most interesting in terms of interaction with the antigen and clinical properties, and its lutetium-177 labeled version has recently been approved by regulatory agencies for therapeutic purposes. For this reasons, the radiolabeling with fluorine-18 of a PSMA-617 derivative might be of interest. Beside other methodologies to radiolabel macromolecules with fluorine-18, the “click-chemistry” approach resulted to be very useful, and the copper-catalyzed azide-alkyne cycloaddition (CuAAC) is considered one of most efficient and reliable. This paper proposes the synthesis of a suitable precursor for the radiolabeling with fluorine-18 of a new PSMA-617 derivative. The whole radiosynthetic procedure has been fully automated, and the final product, which proved to be stable in plasma, has been obtained with radiochemical yield and purity suitable for subsequent preclinical studies.
Articolo in rivista - Articolo scientifico
1,2,3-triazole; automation; click-chemistry; CuAAC; PETPSM; prostate cancer; PSMA ligands; PSMA-617;
English
48
62
15
Iannone, M., Stucchi, S., Turolla, E., Beretta, C., Ciceri, S., Chinello, C., et al. (2022). Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 65(3), 48-62 [10.1002/jlcr.3959].
Iannone, M; Stucchi, S; Turolla, E; Beretta, C; Ciceri, S; Chinello, C; Pagani, L; Todde, S; Ferraboschi, P
File in questo prodotto:
File Dimensione Formato  
Labelled Comp Radiopharmac - 2022 - Iannone - Synthesis and automated fluorine%u201018 radiolabeling of new PSMA%u2010617 derivatives.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 1.81 MB
Formato Adobe PDF
1.81 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/354720
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
Social impact